Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,296 | 14,115 | 10,251 | 8,322 | 17,167 |
| Marketable Securities | 13,543 | N/A | 17,000 | 14,700 | N/A |
| Receivables | 318 | 671 | 1,140 | 326 | 284 |
| TOTAL | $44,567 | $15,264 | $29,004 | $24,472 | $18,321 |
| Non-Current Assets | |||||
| PPE Net | 344 | 354 | 402 | 391 | 376 |
| Investments And Advances | 12,331 | 13,451 | 0 | 0 | 0 |
| Intangibles | 23,082 | 9,751 | 10,087 | 10,805 | 10,282 |
| Other Non-Current Assets | 306 | 167 | 282 | 282 | 0 |
| TOTAL | $36,062 | $23,723 | $10,771 | $11,478 | $10,658 |
| Total Assets | $80,629 | $38,987 | $39,775 | $35,950 | $28,979 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,115 | 12,109 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,891 | 1,367 | 1,807 | 2,010 | 1,865 |
| Accrued Expenses | 299 | 400 | 574 | 675 | 1,065 |
| Other current liabilities | 2,775 | 225 | 367 | 3,541 | N/A |
| TOTAL | $19,350 | $14,710 | $3,355 | $6,860 | $3,716 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 270 | 608 | 606 | 634 | 787 |
| Other Non-Current Liabilities | 47 | 0 | 0 | 5,350 | 10 |
| TOTAL | $94 | $5,171 | $5,386 | $10,938 | $1,792 |
| Total Liabilities | $19,444 | $19,881 | $8,740 | $17,798 | $5,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,140 | 917 | 913 | 795 | 618 |
| Common Shares | 103 | 44 | 44 | 36 | 30 |
| Retained earnings | -177,224 | -152,813 | -139,847 | -128,620 | -114,270 |
| Other shareholders' equity | 729 | 6 | 108 | -49 | -30 |
| TOTAL | $61,185 | $19,106 | $31,035 | $18,152 | $23,471 |
| Total Liabilities And Equity | $80,629 | $38,987 | $39,775 | $35,950 | $28,979 |